Keywords: qlt, begins, ph, iii, photodynamic, drug, cancer

QLT Begins Ph III With Photodynamic Drug In Cancer

Article | 23 December 1996

- QLT PhotoTherapeutics and Ciba Vision have begun Phase III trials with QLT's photodynamic therapy in patients with age-related macular degeneration. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Photofrin

Porfimer Sodium

Go to drug listing